Could Your Apple Watch Check Your Blood Glucose Levels? The Technology is Closer Than You May Think

Keerthi Vedantam

Keerthi Vedantam is a bioscience reporter at dot.LA. She cut her teeth covering everything from cloud computing to 5G in San Francisco and Seattle. Before she covered tech, Keerthi reported on tribal lands and congressional policy in Washington, D.C. Connect with her on Twitter, Clubhouse (@keerthivedantam) or Signal at 408-470-0776.

Could Your Apple Watch Check Your Blood Glucose Levels? The Technology is Closer Than You May Think

Wearable technology has come a long way.

The Apple Watch — often touted as a way to help people monitor their steps and sleep — may soon be able to check your blood sugar levels, making it more akin to a medical device.


Rockley Photonics, a photonic sensor company based in Pasadena, has been quietly working on small blood sensors that can be affixed to wearables and parse alcohol intake, blood sugar and glucose levels. Its biggest customer according to a story from the Telegraph is none other than Apple.

The technology reportedly uses sensors on the back of a smartwatch to shine light through the skin in order to assess blood. Apple and another unnamed company account for as much as 100% of Rockley Photonics' revenue, according to SEC filings.

Neither company replied to requests for comment.

Glucose monitors, once used primarily by diabetics, are reaching the masses. Increasingly companies are offering glucose monitoring services as the obsession with micromanaging one's health grows.

January.ai is a California-based metabolism tracker startup that provides continuous glucose monitors (CGMs) to subscribers, and uses AI to predict what kind of exercise users need to maintain their health. The sticker price for a package is $488. Another —Levels — pairs with an existing CGM to track one's glucose levels at $395. With the added cost of sensors that need to be ordered frequently, these services are out of reach for many, especially for those with type 2 diabetes which has a high correlation with poverty.

What makes glucose monitors more attractive than traditional blood tests is that they continuously track, allowing users to see which foods spike their blood sugar, since different foods have varying results on individuals.

It is unclear if Apple will use this blood sugar monitor the same way January.ai has, but the company (and Rockley) are toeing the line between a consumer health wearable and an actual medical device, which would need to get approval from the Food and Drug Administration. It's a process that could take years to complete, which is incompatible with Apple's typical innovation cycles.

The advent of 24/7 blood sugar monitors that have smartphone capabilities for people to store, track and send data, have been a game changer for diabetics and physicians — doctors can more accurately treat patient health.

"There's also patients who are eating right and are taking all their medicines as prescribed and sometimes putting a CGM on them shows us that, 'oh wow, we've been just treating this patient incorrectly'," said Khan.

But dedicated glucose monitors aren't always reliable — Dexcom came under fire in 2019 when its system stopped notifying patients when their blood sugar was too high or too low, and a parent monitoring their children's diabetes said he was afraid to drop her off at school in case the system failed again.

"These wearable technologies are only as useful to the patients as they are accurate and precise," Khan said. "But because they're so fine-tuned to our diabetes patients, they're a lot less prone to error."

"I certainly wouldn't tell my patients to dose their insulin based on what their Apple Watch is telling them," Khan said. "I would tell them to trust their sensor or trust their fingerstick."

https://twitter.com/KeerthiVedantam
keerthi@dot.la

Subscribe to our newsletter to catch every headline.

Cadence

Data Is Helping Physicians Track Their Patients Health One Heartbeat at a Time

S.C. Stuart
S.C. Stuart is a foreign correspondent (ELLE China, Esquire Latin America), Contributing Writer at Ziff Davis PCMag, and consults as a futurist for Hollywood Studios. Previously, S.C. was the head of digital at Hearst Magazines International while serving as a Non-Executive Director, UK Trade & Investment (US) and Digital Advisor at The Smithsonian.
Data Is Helping Physicians Track Their Patients Health One Heartbeat at a Time

Are you a human node on a health-based digital network?

According to research from Insider Intelligence, the U.S. smart wearable user market is poised to grow 25.5% in 2023. Which is to say, there are an increasing number of Angelenos walking around this city whose vital signs can be tracked day and night via their doctor's digital device. If you've signed up to a health-based portal via a workplace insurance scheme, or through a primary care provider's portal which utilizes Google Fit, you’re one of them.

Do you know your baseline health status and resting heartbeat? Can you track your pulse, and take your own blood pressure? Have you received genetic counseling based on the sequencing of your genome? Do you avoid dairy because it bloats, or because you know you possess the variant that indicates lactose intolerance?

Read moreShow less

Who Will Win the E-scooter Wars in Los Angeles?

Maylin Tu
Maylin Tu is a freelance writer who lives in L.A. She writes about scooters, bikes and micro-mobility. Find her hovering by the cheese at your next local tech mixer.
Who Will Win the E-scooter Wars in Los Angeles?
Evan Xie

Los Angeles — it’s not just beautiful weather, traffic and the Hollywood Walk of Fame — it’s also the largest shared micromobility market in the U.S. with six operators permitted to deploy up to 6,000 vehicles each.

And despite the open market policy, the competition shows no signs of slowing down.

Read moreShow less

March Capital Raises $650 Million Fund to Invest in AI Startups

Samson Amore

Samson Amore is a reporter for dot.LA. He holds a degree in journalism from Emerson College and previously covered technology and entertainment for TheWrap and reported on the SoCal startup scene for the Los Angeles Business Journal. Send tips or pitches to samsonamore@dot.la and find him on Twitter @Samsonamore.

March Capital Raises $650 Million Fund to Invest in AI Startups
March Capital founder Jamie Montgomery. Illustration by Dilara Mundy.

Santa Monica-based venture outfit March Capital announced Feb. 3 that it raised its largest fund to date, a $650 million investment vehicle that will be used to back up to 15 startups focused on delivering new uses of artificial intelligence.

Read moreShow less
https://twitter.com/samsonamore
samsonamore@dot.la
RELATEDEDITOR'S PICKS
LA TECH JOBS
interchangeLA
Trending